SUMMARY To define the sensitivity, specificity and predictive accuracy of two-dimensional echocardiographic detection of left ventricular thrombus, the echocardiograms of 78 patients who had independent proof of the presence or absence of a left ventricular thrombus were interpreted without knowledge of any clinical data. The presence of thrombus was established by autopsy in four patients, by aneurysmectomy in three, and by indium-111 platelet imaging in 15; the absence of thrombus was proved by autopsy in 55 patients and by aneurysmectomy in one patient. The characteristics of true-positive and false-positive echocardiograms, interobserver variability, and clinical features associated with proved thrombus were also defined.
THE DEMONSTRATION of a left ventricular thrombus influences important clinical decisions regarding anticoagulation. Although several reports have described the two-dimensional echocardiographic appearance of left ventricular thrombus, 1-7 no large series has been reported in which the presence or absence of thrombus has been independently verified. Therefore, the accuracy of two-dimensional echocardiographic detection of left ventricular thrombus remains uncertain. In the two largest published studies, surgical or autopsy verification of the echocardiographic findings was available in 14 of 60 patients4 and seven of 25 patients. 6 Ports et al. ' reported a sensitivity of 50% (four of eight). More recently, Al-Nourn et al. ' reported a sensitivity of 72% (13 of 18) and a specificity of 90% (27 of 30) . Thus, the typical echocardiographic features of left ventricular thrombus have usually been described in patients in whom the presence of thrombus has not been confirmed by other techniques.1-7 Also, because the proportion of false-positive echocardiographic diagnoses has been as high as 21% (three of 14) of all positive studies,4 additional information about the causes of false-positive studies is needed.
The purposes of this study were (1) to determine the sensitivity, specificity, and predictive value with which two-dimensional echocardiography can detect left ventricular thrombus; (2) to assess the echocardiographic features of proved thrombus; (3) to define interobserver variability; (4) to determine sources of false-positive echocardiographic diagnoses; and (5) to further define clinical features associated with proved ventricular thrombus and identify patients who are most likely to benefit from an echocardiogram performed to detect left ventricular thrombus.
Methods

Patients
The study population consisted of all patients who underwent two-dimensional echocardiography between January 1, 1979 , and December 31, 1980, in whom independent confirmation of the presence or absence of left ventricular thrombus was also available. During this period, 2459 patients underwent twodimensional echocardiography at one of the two participating hospitals. Eighty-eight of these patients also underwent other studies that established with certainty the presence (23 patients) or absence (65 patients) of left ventricular thrombus. Ten of these patients (one with and nine without thrombus) had technically inadequate echocardiograms and were excluded from further analysis. Thus, echocardiographic and clinical data were reviewed in 78 patients, 22 with and 56 without thrombus. The presence of thrombus was proved by autopsy in four patients, by aneurysmectomy in three and by unequivocally positive indium- 11 scan has never been reported in a patient without thrombus.5 9 10 Thrombus was proved absent by autopsy in 55 patients and by aneurysmectomy in one patient. A platelet scan that failed to demonstrate thrombus was not accepted as proof of the absence of thrombus, because some thrombi are not demonstrated by this technique.5-9 10 The mean age of patients with thrombus was 59.2 ± 13.1 years (+ SD), compared with 56.1 ± 18.6 years in patients without thrombus (NS). All 22 patients with thrombus were male; 19 of the 56 patients without thrombus were female. Clinical embolic events were determined by detailed review of each patient's chart. In all cases of cerebral embolism, the diagnosis was made by a neurologist. The echocardiographic findings in 12 patients (nine with and three without thrombus) have been reported. 5 Autopsies were performed by standard methods.'2 After the heart was removed, a series of parallel horizontal cuts 1 cm apart were made beginning at the apex of the heart and continuing to the base of the papillary muscles. Thus, the entire endocardial surface was well exposed. The presence or absence of left ventricular thrombus was determined by review of the detailed autopsy reports. When available, myocardial sections containing thrombus were reviewed for thrombus size.
Two-dimensional Echocardiography
Two-dimensional echocardiography was performed using either a wide-angle, phased-array sector scanner (Toshiba, 45 patients) or a wide-angle, mechanical sector scanner (A.T.L. Laboratories, 33 patients). Parasternal long-and short-axis and apical two-and four-chamber views were obtained using standard transducer positions. In most studies, nonstandard views were also obtained using apical and low parasternal echocardiographic windows to examine the apex more thoroughly. The mean interval between echocardiography and the definitive demonstration of the presence or absence of thrombus was 1. Thrombus by echocardiography was defined as a distinct mass of echoes in the left ventricular cavity that was seen clearly throughout the cardiac cycle in at least two different echocardiographic views. Additionally, we required this mass to be contiguous with the endocardium in an area of abnormal wall motion. Equivocal echocardiograms were those that met some, but not all, of these criteria. Left ventricular aneurysm was defined as a discrete akinetic or dyskinetic bulge interrupting the normal ventricular contour during diastole and systole. When more than one two-dimensional echocardiogram had been performed, only the study closest in time to surgery, autopsy or platelet imaging was analyzed to determine sensitivity and specificity.
After the initial blinded reading had been analyzed, all false-positive, false-negative, and true-positive studies were reviewed to define the echocardiographic features of true-positive studies and the sources of misinterpretation of the false-negative and false-positive studies.
Indium-ill Platelet Imaging
Platelet labeling was performed as previously described' using a closed bag modification of the technique of Thakur (table 3) . Of the 21 true-positive readings, there was total observer agreement in 19 of the studies (90%). In contrast, there was total observer agreement in only two of the eight false-positive studies (25%) (p < 0.001). Thus, in the nine cases in which there was observer disagreement, the reading by consensus was usually equivocal or positive, and this reading usually proved to be falsely positive for thrombus (six of nine).
Characteristics of True-positive Echocardiograms
In addition to the presence of thrombus, we characterized its location, motion, border, reflectance and approximate size. By echocardiography, 19 of 21 truepositive studies revealed thrombus at the apex; two thrombi were located along the inferior wall in a true aneurysm (patient 19) or a pseudoaneurysm (patient 17). In all but one case, echocardiographic localization of thrombus was confirmed independently. In patient 5, the echocardiographic study done 5 weeks before death suggested a large thrombus in the distal part of an apical aneurysm. At autopsy, only a small thrombus was present at the mouth of the aneurysm. In the 5 weeks between echocardiography and death, the patient had had embolic events to both his brain and kidney, which might explain the apparent discrepancy.
Of the 21 true-positive studies, thrombus motion differing from that of the adjacent myocardial wall was noted in only three (patients 8, 13 and 21). In the remaining 18 patients, thrombus motion was similar to that of the adjacent wall, and the thrombus was attached along a broad base that was generally longer than the free edge of the thrombus (figs. 2 and 3).
In most of the true-positive echocardiograms, thrombi had bright, relatively smooth, well-delineated six of the eight false-positive studies. These artifacts apparently represented reverberations from the transducer itself, from the chest wall or from dense apical myocardial scar. These artifacts appeared as convincing apical intraventricular masses whose borders were often convex towards the ventricular cavity ( fig. 6 ). In one false-positive study in a patient with a large apical aneurysm, the mass of artifact appeared large on the apical long-axis view but markedly smaller on the apical four-chamber view. Such inconsistency in thrombus size when the same area of the ventricle is imaged from different orientations may help detect artifact in some cases, and was not observed in true-positive studies.
In two studies, misinterpretation of the echocardio- This study further establishes the value of twodimensional echocardiography in detecting left ventricular thrombus. The overall sensitivity of 95% and specificity of 86% are similar to previously reported figures in smaller series. 1 4,'8 Using our predefined criteria to diagnose ventricular thrombus, we noted excellent observer agreement (88%) and only minor differences in interobserver sensitivity, specificity and predictive accuracy.
The sensitivity and specificity of echocardiography compare favorably with other invasive and noninvagive techniques for detecting left ventricular thrombus.
Contrast angiography has a sensitivity of 20S50%;;1416 specificity was 75% (39 of 52 patients) in the largest series. 16 We previously reported that noninvasive detection of ventricular thrombus by radionuclide angiography has a sensitivity of 77% (10 of 13 patients) and a specificity of 88% (23 of 26 patients).1' Echocardiography, with its intrinsically higher resolution, generally offers better visualization of ventricular thrombi than does radionuclide angiography. Although a filling defect on the anterior view of the radionuclide angiogram may be a useful clue to the Their data suggest that a more thorough examination of the apex may have been feasible and productive in some of the patients we excluded. Because most thrombi occur at the apex, a study that does not show the apex well does not exclude thrombus. Indeed, one of our patients with a technically inadequate study had thrombus at autopsy.
Another limitation of echocardiography is that, unlike platelet imaging, it may not define thrombus activity. Presumably, fresh and hematologically active thrombi are more likely to embolize than old organized thrombi. In a preliminary report, Mikell et al."8 noted that some recently formed left ventricular thrombi had dynamic mobile echoes of at least two types. These investigators also noted that free intracavitary thrombus motion correlated with embolization. 19 In the current study, echocardiography was performed only after embolic events had occurred; we noted such independent thrombus motion in only three patients. Although two of these three patients had had embolic events, eight other patients with immobile thrombi had also had embolic events. In this study, the echocardiographic size of the thrombus, as estimated visually, did not correlate with embolic events. Thus, in our retrospective review of patients with generally remote myocardial infarction and systemic emboli, we did not identify any echocardiographic feature other than the presence of thrombus that correlated with embolization. Acutely formed thrombi may have echocardiographic characteristics predictive of embolization that differ from those of chronically formed thrombi. Prospective studies are needed to define echocardiographic features predictive of embolization in both patient groups.
Minimizing False-positive Diagnoses
The main limitation of the echocardiographic diagnosis of thrombus in this study was that eight of 29 FIGURE 6 . Apicalfour-chamber view (above) and apical two-chamber views (below) from a false-positive study obtained 1 week before autopsy show an artiftictual echo-dense apical mass bulging conve-xly into the ventricle (patient 30). In the top and lower right panels, the artifact border is not well defined and was inconsistently present in real-time display. 95% . Thus, equivocal studies should probably be considered negative. In addition, studies in which there was observer disagreement were more likely to be falsely positive (six of eight, 75%) than studies in which there was observer agreement (two of 20, 10%) (p < 0.01). In difficult cases, if multiple experienced observers disagree, the study should probably be interpreted as negative. Thrombi that appeared small (less than 1.0 cm in the largest dimension) were falsely positive in four of five cases. Thus, assessment of thrombus size may help minimize false-positive diagnoses. Anatomic alterations from ventricular surgery or prominent trabeculation in hypertrophied ventricles may also be misinterpreted as thrombi. In this series, such anatomic variants also presented as small defects. Artifactual filling defects originating from reverberations in the near field generally had a convex border bulging into the left ventricular cavity; at least some portion of true thrombi was usually concave. Also, some artifacts simulating thrombi had multiple bright radial lines. When such lines projected beyond the myocardium, they were easily distinguished from thrombus, but when they appeared completely within the ventricle, as in patients with large hearts, distinguishing artifact from thrombus was often difficult. Artifacts did not have motion independent of the ventricular or chest wall, but in our series neither did most proved thrombi. In many false-positive cases, the artifact-blood boundary was not as distinct or sharp as the borders of true thrombi. Thrombi were consistent in size and location from view to view; artifacts often were not. Thus, views using multiple transducer locations with variable gain settings may help distinguish artifact from thrombus ( fig. 4) .
Clinical Features Associated with Ventricular Thrombi
Clinical features that were very common in patients with left ventricular thrombi included transmural anterior myocardial infarction and ventricular aneurysm. In addition, left ventricular ejection fraction tended to be lower in patients with than in those without thrombus, as previously described." These findings are in agreement with earlier clinical and autopsy studies that showed that anterior infarction, 7 11 21 transmural in- 25 29 and idiopathic dilated cardiomyopathy.30 Awareness of these factors may increase the clinical suspicion of thrombus and lead to earlier identification of patients at risk for systemic embolization. In addition, the absence of these clinical features defines a group of patients who are at very low risk for left ventricular thrombus. This group, which is composed of patients without either transmural anterior infarction, left ventricular aneurysm or low ejection fraction, would be very unlikely to benefit from echocardiography performed to rule out left ventricular thrombus.
The frequency with which ventricular thrombi cause clinically significant embolic events is unknown. Several studies in which left ventricular thrombus was diagnosed during life by either contrast angiography or echocardiography have suggested that less than 25% of patients with ventricular thrombus have clinically detected embolization.471 16.20 A NEW CLASS of ultrasound contrast agents has been developed that offer the possibility of determining the distribution of myocardial blood flow with two-dimensional echocardiography. These agents are encapsulated gas microbubbles, which are highly reflectant and are the source of ultrasonic contrast effect. ' When in-jected into the circulation, these microbubbles produce an intense contrast effect that lasts several seconds to several minutes. The degree of contrast enhancement is considerably greater than that provided by agents such as indocyanine green dye and saline.' 2 When injected into the coronary circulation, the microbubbles reproducibly and markedly increase the intensity of the echocardiographic image of the myocardium ( fig. 1 ). This effect is not seen after injecting standard contrast agents.3 To test whether one of these agents, gelatin-encapsulated microbubbles, could serve as a marker for left ventricular perfusion, we compared two-dimensional echocardiographic videodensity after the injection of gelatin-encapsulated microbubbles with myocardial blood flow measured with radiolabeled microspheres. The presence or absence of concurrent wall motion abnormalities was also evaluated as a marker for myocardial ischemia, and compared with results of contrast echocardiography and myocardial perfusion studies.
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